Delete search term


Quick navigation

Main navigation

Competence Centre TEDD

Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement).

REGISTRATION OPEN: 7 June 2023 TEDD Visit: University of Zurich Department of Pathology and Molecular Pathology

TEDD Partners have an opportunity to visit University of Zurich Department of Pathology and Molecular Pathology.



Deadline for registration is 31st May 2023.


8 September 2023 TEDD Annual Meeting 2023: Clinical applications of advanced cell culture models


Confirmed Speakers

Prof Javad Nazarian, University Childrens‘ Hospital Zurich, Oncology Department

From biopsy to cure: a challenge for precision oncology

Bianca Fischli , ZHAW/TEDD (Team of Prof. Michael Raghunath)

Vascular pattern making using sound induced morphogenesis – experience with the first commercial CymatiX instrument

Prof Benjamin Gantenbein, University of Bern, Medical Faculty, Department for BioMedical Research

­What regeneration in orthopaedics might bring to an increasingly elderly society

Dr Arno Amann, Department of Haematology and Oncology, Medical University of Innsbruck

title tbc

Dr Markus Mühlemann, Kugelmeiers

The role of standardized spheroids in pancreatic islet transplantation

Dr Deana Mohr, MUVON Therapeutics

MUVON from bench to bedside




The exhibition call is open in. TEDD Partners Exhibit for free and have priority.

Please contact Kasia Kopanska at to book your booth.

If you are not TEDD Parter and would like to exhibit please Join TEDD as Partner

TEDD Events 2023 - Check the dates update!

NEW TEDD Partner Sino Biological

We welcome a new TEDD Partner!

Sino Biological is dedicated to providing the scientific community with high-quality recombinant protein and antibody reagents to promote life science research and drug discovery. 

With the largest validated recombinant protein bank (6000+), a broad range of antigens are covered, including viral proteins, cytokines and growth factors, immune checkpoints, antigens for CAR-T cell therapy, Fc receptors, biomarker proteins, etc, as well as a comprehensive collection of high quality mono- and polyclonal antibodies. 

Based on our rich experiences and expertise, several robust recombinant protein expression platforms and antibody discovery methods have been established for customized contracted research projects.

TEDD Partners

TEDD Partnership Fee 2023

Yearly TEDD Partnership fee 2023 is CHF 500.

TEDD Partnership conditions:

  • Two people from TEDD Partner organization can attend TEDD events free of charge. Subsequent people from this organization will receive a 50% discount for that event.
  • TEDD Partnership period is from January to December of the given year.
  • TEDD Partnership extends for the following year unless cancelled.
  • TEDD Partner can cancel partnership latest on 30 November of the current year effective next year by sending us an email on

Join TEDD as Partner



About TEDD

TEDD Competence Centre (Tissue Engineering for Drug Development and Substance Testing)

TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.

Read more about TEDD

TEDD Flyer(PDF 1,1 MB)